IRIS
SILINI, ENRICO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.449
EU - Europa 1.100
AS - Asia 888
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.435
CN - Cina 795
IE - Irlanda 341
UA - Ucraina 200
DE - Germania 173
FI - Finlandia 160
SE - Svezia 76
SG - Singapore 67
IT - Italia 52
GB - Regno Unito 45
FR - Francia 32
JP - Giappone 17
CA - Canada 14
CZ - Repubblica Ceca 9
VN - Vietnam 6
BE - Belgio 5
EU - Europa 3
AU - Australia 2
CH - Svizzera 2
IN - India 2
NL - Olanda 2
IR - Iran 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 3.443
Salva come PNG Salva come JPEG
Città #
Dublin 341
Chandler 335
Jacksonville 295
Nanjing 238
Ashburn 102
Boardman 99
Nanchang 88
Beijing 83
Princeton 69
Hebei 68
Lawrence 63
Shenyang 60
Wilmington 59
Jiaxing 51
Changsha 46
Tianjin 45
Singapore 40
Hangzhou 39
Medford 37
Munich 32
Helsinki 29
Ann Arbor 23
Milan 23
Shanghai 19
Verona 17
Tokyo 16
Norwalk 15
Woodbridge 12
Toronto 11
Brno 8
Des Moines 8
Kunming 8
Auburn Hills 7
Jinan 7
Dearborn 6
Dong Ket 6
Brussels 5
Guangzhou 5
Falls Church 4
New York 4
Zhengzhou 4
Berlin 3
Changchun 3
Los Angeles 3
Washington 3
Basel 2
Borås 2
Costa Mesa 2
Dallas 2
Falkenstein 2
Houston 2
Lodi 2
London 2
Ningbo 2
Orange 2
Seattle 2
Taizhou 2
Xingtai 2
Adelaide 1
Billings 1
Bristol 1
Chengdu 1
Comazzo 1
Corbetta 1
Fairfield 1
Gunzenhausen 1
Haikou 1
Hamilton 1
Hefei 1
Jingmen 1
Lanzhou 1
Las Vegas 1
Liverpool 1
Monmouth Junction 1
Nuremberg 1
Ottawa 1
Piacenza 1
Redwood City 1
Rockville 1
San Francisco 1
San Jose 1
Santa Clara 1
Terrebonne 1
Wetaskiwin 1
Zanjan 1
Totale 2.492
Salva come PNG Salva come JPEG
Nome #
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 88
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 78
Su di uno "strano" epatocarcinoma 77
Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities. 76
Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology 74
Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection 71
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 70
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 70
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 68
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 68
Clinical significance of hepatitis C virus genotypes. 66
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 66
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 66
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 65
Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. 64
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 63
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 63
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 63
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 62
HCV viremia in hemodialysis patients 62
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 61
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 60
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 59
Association between class II allelles and protection or susceptibility to chronic hepatitis C 58
Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples 58
Comparative evaluation of two serologic typing methods of hepatitis C virus 57
HCV genotypes in the development of hepatocellular carcinoma (HCC) in anti-HCV positive cirrhotic patients: preliminary report of a prospective study 57
Comparative evaluation of two serological typing methods for hepatitis C virus 57
Polymporphisms of P450 genes and risk of hepatocellular carcinoma in HCV-infected patients. 56
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 55
Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. 55
Hepatitis C virus core serotypes in haemodialysis patients 53
Hepatitis C virus (HCV) infection in children treated for acute lymphoblastic leukemia (ALL) 53
Antibody responses to hepatitis C virus hypervariable regione 1: evidence for cross-reactivity and immune-mediated sequence variation 53
Analysis of hepatitis C virus hypervariable region 1 sequence in cryoglobulinaemic patients and associated control 53
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 52
Multiple Papillomavirus Infection and Size of Colposcopic Lesions Among Women With Cervical Intraepithelial Neoplasia 52
HLA-DQA1, DQB1 heterodimers in chronic hepatitis C 52
Virological features of HCV infection in hemodialysis patients 51
HLA genes and chronic hepatitis C severity 51
Hypervariable region 1 (HVR1) of HCV: immunological decoy or biologically relevant domain? 50
HGV-GBV-C infection in liver transplant recipients. Antibodies to the viral E2 envelope glycoprotein protect from de novo infection 50
Comparative evaluation of HCV core genotyping and serotyping 49
Different spectrum of liver disease in patients with HCV genotype II and III infection 46
Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies 45
Hepatitis C virus infection in children treated for acute lymhoblastic leukemia 44
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study 43
Vertical trasnmission of hepatitis C 41
HLA class II and III and severity of hepatitis C virus (HCV)-related chronic liver disease 40
High prevalence of hepatitis C virus genotype III infection in patient with normal liver enzymes and mild histologic lesions 40
Hepatitis C virus genotypes and risk of cirrhosis in Southern Italy 40
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. 39
Dynamic of hypervariable region 1 (HVR1) variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease 39
HVR1 variation, viral type and ALT values in chronic HCV infection 38
Molecular epidemiology of HCV infection in drug addicts 37
Genotipi del virus dell'epatite C e rischio di carcinoma epatocellulare: uno studio prospettico 37
Prevalenza di esposizione ad HGV in un day-hospital oncologico pediatrico 37
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study 37
Significance of hepatitis C virus genotypes 36
Virological feaures of hepatitis C virus infection in hemodialysis patients 35
Polymorphysms of glutathione s-trasnferase and epoxide hydrolase and severity of HCV-related liver disease 35
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. 32
null 30
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 30
Molecular epidemiology of hepatitis C virus infection among inravenous drug users 26
Phylogenetic analysis of hepatitis G virus (HGV) 5'-non coding regione and development of a rapid PCR-based typing assay 25
Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable regione 1 in hepatitis C viremic patients 23
Totale 3.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.422
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020227 0 0 0 0 0 39 8 43 1 88 47 1
2020/2021372 38 32 10 37 1 54 1 59 10 65 48 17
2021/2022234 0 1 12 3 2 12 1 11 18 7 43 124
2022/2023982 125 77 6 69 108 99 0 55 403 8 25 7
2023/2024266 23 55 6 32 27 57 1 23 1 6 9 26
2024/2025194 30 76 40 28 2 18 0 0 0 0 0 0
Totale 3.507